Alpha 2.0
Login Register
» Authors » Y U Imai

Y U Imai

Explore the profile of Y U Imai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 2
Citations 0
Followers 0
Related Specialty
Oncology
Top 10 Co-Authors
Fumihiko Urabe
Takahiro Kimura
Kojiro Tashiro
Kosuke Iwatani
Takafumi Yanagisawa
Kenta Miki
Keiichiro Miyajima
Jun Miki
Yusuke Koike
Manabu Aoki
Published In
Anticancer Res
In Vivo
Affiliations
Soon will be listed here.
Recent Articles
1.
Novel Preoperative Immune Prognostic Index for Predicting Outcomes in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Shibata K, Iwatani K, Imai Y, Yoshihara K, Miyajima K, Fukuokaya W, et al.
In Vivo . 2025 Feb; 39(2):824-833. PMID: 40010955
Background/aim: The lung immune prognostic index (LIPI), which is determined by assessing the derived neutrophil-to-lymphocyte ratio in conjunction with the level of lactate dehydrogenase, predicts outcomes in various cancers. Its...
2.
The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate Cancer
Urabe F, Kobayashi D, Iwatani K, Imai Y, Onuma H, Aikawa K, et al.
Anticancer Res . 2023 Sep; 43(10):4611-4617. PMID: 37772549
Background/aim: Clinical trials have shown that the efficacy of a reduced dose of cabazitaxel (20 mg/m every 3 weeks) was not inferior to that of the standard dose (25 mg/m...
3.
Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer
Suzuki H, Urabe F, Iwatani K, Miyajima K, Imai Y, Tashiro K, et al.
Anticancer Res . 2023 Jun; 43(7):3135-3143. PMID: 37352008
Background/aim: A recent clinical trial indicated the usefulness of local radiation therapy of the prostate in patients with low-volume metastatic prostate cancer. High-dose-rate brachytherapy (HDR-BT) is used mainly for high-risk,...